{
  "id": "adv_mhgap#risk_safety_3b760238",
  "content": "stressors (e.g. domestic abuse, unemployment)\ntheir results.\nassociated with methamphetamine or cocaine\ny Mirtazapine is a promising alternative that was\nuse and dependence and include appropriate\nfound to have a relevant impact on subgroups\npsychosocial interventions in their treatment plan.\n(cisgender men and transgender women who have\ny The costs of the medicines evaluated here can vary\nsex with men).\nbetween countries. There is very little literature\ny The combination of depot naltrexone and bupropion\non cost-effectiveness and pharmacoeconomic\nhad a small but statistically significant impact on\naspects in general for medicines to treat\nmethamphetamine use in a recent trial.\nmethamphetamine dependence.\ny Any treatment or support for people using drugs\ny If implemented, any psychopharmacological\nor with drug use disorders should ensure ethical\ntreatment of stimulant dependence should carefully\nstandards – including respect for human rights and\nconsider the specific clinical characteristics of\nthe individual’s dignity, and never using humiliating\neach person receiving the treatment (e.g. higher\nor degrading interventions – in line with the\nrisk of psychotic episodes with prescription\nWHO and UNODC International standards for the\npsychostimulants among individuals with previous\ntreatment of drug use disorders (147) (see Box 3.1).\nhistory of psychosis). The medicine choice should",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "risk_safety",
      "screening_cues",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Risk Safety stressors (e.g. domestic abuse, unemployment)\ntheir results.\nassociated with methamphetamine or cocaine\ny Mirtazapine is a promising alternative that was\nuse and dependence and include appropriate\nfound to have a relevant impact on subgroups\npsychosocial interventions in their treatment plan.\n(cisgender men and transgender women who have\ny The costs of the medicines evaluated here can vary\nsex with men).\nbetween countries. There is very little literature\ny The combination of depot naltrexone and bupropion\non cost-effectiveness and pharmacoeconomic\nhad a small but statistically significant impact on\naspects in general for medicines to treat\nmethamphetamine use in a recent trial.\nmethamphetamine dependence.\ny Any treatment or support for people using drugs\ny If implemented, any psychopharmacological\nor with drug use disorders should ensure ethical\ntreatment of stimulant dependence should carefully\nstandards – including respect for human rights and\nconsider the specific clinical characteristics of\nthe individual’s dignity, and never using humiliating\neach person receiving the treatment (e.g. higher\nor degrading interventions – in line with the\nrisk of psychotic episodes with prescription\nWHO and UNODC International standards for the\npsychostimulants among individuals with previous\ntreatment of drug use disorders (147) (see Box 3.1).\nhistory of psychosis). The medicine choice should Stressors (e.g. domestic abuse, unemployment)\ntheir results."
}